Why Nestlé Shares Crashed 7% in July 2026: H1 Profit Plunge, Infant Formula Recall, and the Peranel JV Explained

While Nestlé's organic sales grew solidly at 3.6% and real internal volume growth accelerated, the market focused on the bottom-line shock: a 31.4% collapse in net profit, heavy impairment charges, the lingering impact of an infant formula recall, and a complex portfolio move that all landed on the same day.

The Numbers That Spooked the Market

Nestlé's first-half 2026 results, released on July 23, showed a sharp divergence between topline momentum and profitability :

Organic growth beat expectations at 3.6%, and RIG — a measure of volume-driven demand — accelerated from 1.2% in Q1 to 1.8% in Q2, signaling a genuine demand recovery . Underlying EPS rose 4% in constant currency .

But these operational improvements were completely overshadowed by the reported net profit collapse.

What Drove the 31.4% Profit Decline

The net profit drop from CHF 5.065 billion to CHF 3.472 billion had three primary causes :

Restructuring and impairment costs. Nestlé booked significant write-downs on assets held for sale, a direct cost of the water joint venture restructuring . Restructuring and net other trading items reached CHF 0.8 billion, up from CHF 0.4 billion in H1 2025 .

Portfolio-related charges. Costs tied to the water joint venture and other portfolio moves added further pressure .

Weaker reported revenues. Sales fell 2.5% to CHF 43.11 billion, even as organic growth improved. The gap reflects currency headwinds, commodity cost inflation, and the effects of the infant formula recall .

The Infant Formula Recall: A Lingering Drag

In January 2026, Nestlé launched a global precautionary recall of certain batches of SMA, BEBA, NAN, and Guigoz infant formulas after detecting cereulide toxin in arachidonic acid oil supplied by a third-party supplier . The recall, later expanded in France , had immediate financial consequences :

• In Q1 2026, the recall knocked approximately 90 basis points off organic growth — roughly half from direct sales returns and half from temporary stock shortages .
• The Nutrition category became the only segment to decline in H1, with organic growth of -1.2% .
• The recall contributed to the 20 bps gross margin decline through returns and higher costs .
• Management acknowledged that some parents would permanently switch brands , creating lingering brand recovery risk.

The financial impact was substantial even before H1: Nestlé disclosed a CHF 185 million hit to its 2025 results from the same recall .

The Peranel Water Joint Venture: A Long-Awaited Restructuring

On the same day as the earnings release, Nestlé announced it would transfer its premium water brands — including Perrier, S.Pellegrino, and Acqua Panna — into a new 50/50 joint venture called Peranel with private equity firm Platinum Equity .

Key deal terms :

• Nestlé expects to raise €3 billion (~CHF 2.8 billion, $3.43 billion) in cash at closing.
• The transaction values the water and premium beverages business at €4.9 billion ($5.6 billion) including cash and debt.
• The joint venture, headquartered in Paris, will be led by Muriel Lienau and hold more than 30 brands sold in 120 countries.
• The deal had been in negotiation since 2024; Platinum emerged as the sole remaining bidder in June 2026 after Clayton Dubilier & Rice withdrew .
• Closing is expected in the first half of 2027, subject to regulatory approvals and employee consultation.

The move is designed to streamline Nestlé's operations and allow the water business to grow more nimbly as a standalone entity . However, the deal required Nestlé to write down assets held for sale, which directly depressed reported earnings and added to investor unease .

Why Maintained Full-Year Guidance Didn't Help

Nestlé confirmed its full-year 2026 outlook, including expectations for gross margin improvement versus 2025 . On the earnings call, management highlighted CHF 600 million in incremental cost savings and improving volume trends .

But the guidance failed to reassure the market for several reasons :

• The sheer scale of the 31.4% profit decline and CHF 0.8 billion in one-time charges overwhelmed the positive signals.
• The water JV, while strategically sound, involved writing down assets held for sale, muddying reported earnings.
• Ongoing currency headwinds, commodity inflation (coffee, cocoa), and tariff pressure clouded the outlook.
• The infant formula recall created lasting uncertainty about brand recovery and regulatory risk.

As one analyst noted, the market punished Nestlé's high valuation because the results fell short of expectations . The stock's decline alone knocked the broader STOXX 600 index and made Nestlé the largest negative influence on the Swiss SMI that day .

The fundamental story was mixed: Nestlé was executing better operationally, but the combination of a profit shock, heavy one-off charges, and a complex portfolio restructuring in a single day overwhelmed any positive news.

Key Takeaway

Nestlé's July 2026 share rout was not caused by a single factor but by the simultaneous collision of a profit miss, an infant formula recall still weighing on results, and a strategically necessary but financially painful water joint venture. The 7% drop reflected the market's verdict that the combination of short-term earnings pain and long-term restructuring uncertainty would take time to resolve.